Insider Transactions in Q2 2025 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2025
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,868
+15.13%
|
-
|
|
Jun 11
2025
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,868
+2.41%
|
-
|
|
Jun 11
2025
|
Cathy Klema Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,868
+31.34%
|
-
|
|
Jun 11
2025
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,868
+14.72%
|
-
|
|
Jun 11
2025
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,868
+11.96%
|
-
|
|
May 15
2025
|
Stephen L Silvestro Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,948
+21.82%
|
-
|
|
May 15
2025
|
Theresa Greco Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,483
+7.41%
|
-
|